TRAjectories and Clinical ExpeRiences of ICD Therapy (TRACER-ICD) Study

Overview

Información sobre este estudio

The TRACER-ICD Study will be a 60 month study (9 months preparation, 45 months to conduct the study, 6 months data analysis and manuscript preparation) in which a prospective cohort of 500 patients receiving ICDs as part of clinical care at 5 sites will be followed for up to 18 months or death, with data collected from patient or proxy interviews (baseline, in-person; quarterly, by telephone) and electronic record reviews (baseline and quarterly), including remote monitoring data. Data collected through these complementary methods will be used to describe the following aspects of patients’ clinical course:

  • focused geriatric assessment (e.g., frailty, cognition, functional status);
  • comorbidities;
  • quality of life;
  • advance care planning;
  • health services use;
  • SDM;
  • ICD-recorded physical activity (minutes/day).
  • Factors associated with death and poor quality of life (Kansas City Cardiomyopathy Questionnaire [KCCQ] score < 60 or decline by > 10) will be identified. Group-based trajectory modeling will be used to identify clusters of patients with distinct trajectories of functional status and quality of life following ICD implantation (Aim 1). We will validate our semi-competing risks model to jointly assess ICD shocks and survival (Aim 2). Lastly, we will combine quantitative data on SDM experiences from the main cohort with semi-structured interviews of cardiologists and patients to evaluate strategies for incorporating personalized profiling into SDM (Aim 3).

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Patient receiving new primary prevention ICD (excluding cardiac resynchronization therapy).
  • Age ≥ 65 years.
  • English-speaking (assessment instruments are only available/validated in English).
  • Sufficient cognitive ability to provide consent (i.e., answer simple questions on study participation, purpose and procedures).

Exclusion Criteria:

  • Individuals < 65 years.
  • Non-English speaking.
  • Inability to provide consent.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Peter Noseworthy, M.D., M.B.A.

Abierto para la inscripción

Contact information:

Laura Peterson

(507) 255-7456

Peterson.Laura@mayo.edu

More information

Publicaciones

Publications are currently not available
.
CLS-20537869

Mayo Clinic Footer